Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    February 2017
  1. MAZZOLAI L, Aboyans V, Ageno W, Agnelli G, et al
    Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.
    Eur Heart J. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format    


    January 2017
  2. RENOUX C, Coulombe J, Suissa S
    Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.
    Eur Heart J. 2017 Jan 10. pii: ehw613. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. REINER MF, Breitenstein A, Holy EW, Glanzmann M, et al
    Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Eur Heart J. 2017 Jan 8. pii: ehw578. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. DE CARLO M, Mazzolai L, Bossone E, Brodmann M, et al
    The year in cardiology 2016: peripheral circulation.
    Eur Heart J. 2017 Jan 2. pii: ehw643. doi: 10.1093.
    PubMed     Text format    


    November 2016
  5. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    October 2016

  6. Racing against time in acute ischaemic stroke treatment.
    Eur Heart J. 2016;37:2856-2857.
    PubMed     Text format    


    September 2016
  7. PICCINI JP, Sievert H, Patel MR
    Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  8. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  9. FOX KA
    CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%.
    Eur Heart J. 2016;37:860-1.
    PubMed     Text format    


  10. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Text format     Abstract available


  11. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


  12. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Text format     Abstract available


  13. WAKSMAN R, Rogers T
    CardioPulse: Transcatheter aortic valve replacement.The American perspective on transcatheter aortic valve replacement.
    Eur Heart J. 2016;37:797-9.
    PubMed     Text format    


    February 2016
  14. TRUCHANOWICZ E, Kirchhof P
    CardioPulse: New perspectives for stroke prevention in atrial fibrillation.
    Eur Heart J. 2016;37:583-4.
    PubMed     Text format    


  15. STEFFEL J, Jais P, Hindricks G
    The year in cardiology 2015: arrhythmias and device therapy.
    Eur Heart J. 2016;37:587-93.
    PubMed     Text format    


    January 2016
  16. IUNG B, Rahimtoola SH, Vahanian A
    The year in cardiology 2015: valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Text format    


    November 2015
  17. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  18. HAMM CW, Arsalan M, Mack MJ
    The future of transcatheter aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  19. WIDIMSKY P, Hopkins LN
    Catheter-based interventions for acute ischaemic stroke.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  20. O'BRIEN EC, Simon DN, Thomas LE, Hylek EM, et al
    The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  21. KOTECHA D, Piccini JP
    Atrial fibrillation in heart failure: what should we do?
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  22. SKOLOUDIK D, Kuliha M, Hrbac T, Jonszta T, et al
    Sonolysis in Prevention of Brain Infarction During Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  23. LUSCHER TF
    Stroke: cardiac causes and their management.
    Eur Heart J. 2015;36:2339-41.
    PubMed     Text format    


  24. KENT DM, Dahabreh IJ, Ruthazer R, Furlan AJ, et al
    Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.
    Eur Heart J. 2015;36:2381-9.
    PubMed     Text format     Abstract available


  25. SARDAR P, Chatterjee S, Giri J, Kundu A, et al
    Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2015;36:2373-80.
    PubMed     Text format     Abstract available


  26. VINEREANU D, Stevens SR, Alexander JH, Al-Khatib SM, et al
    Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  27. LIP GY
    The CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.
    Eur Heart J. 2015.
    PubMed     Text format    


  28. LIP GY, Lane DA
    Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
    Eur Heart J. 2015.
    PubMed     Text format    


  29. CAMM AJ, Amarenco P, Haas S, Hess S, et al
    XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    August 2015
  30. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  31. SHARMA R, Oni OA, Gupta K, Chen G, et al
    Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  32. TAYLOR J
    Hand grip strength predicts myocardial infarction and stroke.
    Eur Heart J. 2015;36:1845.
    PubMed     Text format    


    July 2015
  33. STONE GW, Adams DH, Abraham WT, Kappetein AP, et al
    Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  34. DENEGRI A, Pedrazzini GB, Moccetti T, Moccetti M, et al
    Calcification of the mitral valve complicated by embolization and subsequent ischemic stroke with haemorrhagic transformation.
    Eur Heart J. 2015.
    PubMed     Text format    


  35. LUSCHER TF MD FESC
    Novel risk markers and mediators in coronary disease and stroke.
    Eur Heart J. 2015;36:1557-1559.
    PubMed     Text format    


  36. JAMES S
    Stroke: a rare but devastating procedural complication of PCI.
    Eur Heart J. 2015;36:1571-2.
    PubMed     Text format    


  37. VOLPE M, Paneni F
    Shooting vascular oxidative stress: new hopes for stroke patients?
    Eur Heart J. 2015;36:1573-5.
    PubMed     Text format    


  38. SPESCHA RD, Klohs J, Semerano A, Giacalone G, et al
    Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
    Eur Heart J. 2015;36:1590-600.
    PubMed     Text format     Abstract available


    June 2015
  39. JOLLY SS, Cairns JA, Yusuf S, Meeks B, et al
    Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  40. POKORNEY SD, Granger CB
    Should patients on vitamin K antagonists be treated differently?
    Eur Heart J. 2015;36:1431-3.
    PubMed     Text format    


  41. O'DONOGHUE ML, Ruff CT, Giugliano RP, Murphy SA, et al
    Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillationdagger.
    Eur Heart J. 2015;36:1470-7.
    PubMed     Text format     Abstract available


  42. LANZER P, Widimsky P
    Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach.
    Eur Heart J. 2015.
    PubMed     Text format    


    May 2015
  43. COSTA F, Vranckx P, Leonardi S, Moscarella E, et al
    Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment A
    Eur Heart J. 2015;36:1242-51.
    PubMed     Text format     Abstract available


  44. SCHULZ-SCHUPKE S, Byrne RA, Ten Berg JM, Neumann FJ, et al
    ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
    Eur Heart J. 2015;36:1252-63.
    PubMed     Text format     Abstract available


  45. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  46. JERNBERG T, Hasvold P, Henriksson M, Hjelm H, et al
    Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.
    Eur Heart J. 2015;36:1163-70.
    PubMed     Text format     Abstract available


  47. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  48. KARANASOS A, Van Mieghem NM, Regar E, Daemen J, et al
    Serial imaging observations of vascular healing in a denervation-induced renal artery dissection.
    Eur Heart J. 2015;36:1040.
    PubMed     Text format    


  49. VAN DER DONCKT C, Van Herck JL, Schrijvers DM, Vanhoutte G, et al
    Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.
    Eur Heart J. 2015;36:1049-58.
    PubMed     Text format     Abstract available


    April 2015
  50. KWOK CS, Kontopantelis E, Myint PK, Zaman A, et al
    Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    March 2015
  51. LANZER P
    CardioPulse: STEMI and stroke: distant cousins at best.
    Eur Heart J. 2015;36:590.
    PubMed     Text format    


    February 2015
  52. ALIOT E, Brandes A, Eckardt L, Elvan A, et al
    The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Eur Heart J. 2015;36:255-6.
    PubMed     Text format    


  53. HEIDBUCHEL H, Hindricks G
    The year in cardiology 2014: arrhythmias and device therapy.
    Eur Heart J. 2015;36:270-8.
    PubMed     Text format     Abstract available


    January 2015
  54. CREMONESI A, Castriota F, Secco GG, Macdonald S, et al
    Carotid artery stenting: an update.
    Eur Heart J. 2015;36:13-21.
    PubMed     Text format     Abstract available


    December 2014
  55. TANIWAKI M, Windecker S, Raber L
    Silent myocardial infarction and stroke: findings of multimodality imaging.
    Eur Heart J. 2014.
    PubMed     Text format    


  56. HELD C, Hylek EM, Alexander JH, Hanna M, et al
    Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Eur Heart J. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: